GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 827 filers reported holding GLAXOSMITHKLINE PLC in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $499,269 | -35.4% | 14,208 | -20.0% | 0.11% | -35.3% |
| Q2 2022 | $773,000 | -0.1% | 17,761 | 0.0% | 0.17% | +14.6% |
| Q1 2022 | $774,000 | -1.1% | 17,761 | 0.0% | 0.15% | -15.2% |
| Q4 2021 | $783,000 | +15.3% | 17,761 | 0.0% | 0.18% | +5.3% |
| Q3 2021 | $679,000 | -4.0% | 17,761 | 0.0% | 0.17% | -3.4% |
| Q2 2021 | $707,000 | +11.5% | 17,761 | 0.0% | 0.18% | +4.2% |
| Q1 2021 | $634,000 | -3.1% | 17,761 | 0.0% | 0.17% | -8.7% |
| Q4 2020 | $654,000 | -2.2% | 17,761 | 0.0% | 0.18% | -11.5% |
| Q3 2020 | $669,000 | -7.6% | 17,761 | 0.0% | 0.21% | -16.8% |
| Q2 2020 | $724,000 | +7.6% | 17,761 | 0.0% | 0.25% | -5.7% |
| Q1 2020 | $673,000 | -19.4% | 17,761 | 0.0% | 0.26% | -0.7% |
| Q4 2019 | $835,000 | +10.2% | 17,761 | 0.0% | 0.27% | +1.5% |
| Q3 2019 | $758,000 | +6.6% | 17,761 | 0.0% | 0.26% | +3.5% |
| Q2 2019 | $711,000 | -4.2% | 17,761 | 0.0% | 0.25% | -5.9% |
| Q1 2019 | $742,000 | +9.3% | 17,761 | 0.0% | 0.27% | -4.6% |
| Q4 2018 | $679,000 | -4.8% | 17,761 | 0.0% | 0.28% | +8.8% |
| Q3 2018 | $713,000 | -0.4% | 17,761 | 0.0% | 0.26% | -8.5% |
| Q2 2018 | $716,000 | -20.0% | 17,761 | -22.4% | 0.28% | -21.5% |
| Q1 2018 | $895,000 | +10.2% | 22,901 | 0.0% | 0.36% | +12.8% |
| Q4 2017 | $812,000 | -12.7% | 22,901 | 0.0% | 0.32% | -18.1% |
| Q3 2017 | $930,000 | -5.8% | 22,901 | 0.0% | 0.39% | -8.8% |
| Q2 2017 | $987,000 | -4.8% | 22,901 | -6.9% | 0.43% | -9.1% |
| Q1 2017 | $1,037,000 | +9.5% | 24,591 | 0.0% | 0.47% | +5.6% |
| Q4 2016 | $947,000 | -10.7% | 24,591 | 0.0% | 0.45% | -11.8% |
| Q3 2016 | $1,061,000 | -0.5% | 24,591 | 0.0% | 0.51% | -3.4% |
| Q2 2016 | $1,066,000 | +6.9% | 24,591 | 0.0% | 0.53% | +2.7% |
| Q1 2016 | $997,000 | -20.2% | 24,591 | -20.7% | 0.51% | -18.2% |
| Q4 2015 | $1,250,000 | +4.9% | 30,991 | 0.0% | 0.63% | +1.8% |
| Q3 2015 | $1,192,000 | -7.7% | 30,991 | 0.0% | 0.62% | -3.0% |
| Q2 2015 | $1,291,000 | -9.7% | 30,991 | 0.0% | 0.63% | -8.4% |
| Q1 2015 | $1,430,000 | -8.0% | 30,991 | -14.8% | 0.69% | -5.1% |
| Q4 2014 | $1,555,000 | – | 36,391 | – | 0.73% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |